Cumberland Pharmaceuticals Inc.

NASDAQ:CPIX

Drug Manufacturers - Specialty & Generic

Healthcare
$6.57 -1.07%

-$0.06 today

Market cap
$98.52M
Beta
0.10
P/E (TTM)
-11.5
EPS (TTM)
-$0.48
52W Low $1.85High $6.61

Volume 0.16M

Average 0.97M

CPIX Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

Cumberland Pharmaceuticals Inc.NASDAQ: CPIX

Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Investing cash flow dips below year-ago levels

Q1 FY2026 investing cash flow of $61.17K (cash outflow) fell 95.0% year over year, behind the +218.3% change in trailing-twelve-month investing cash flow. Sequentially, it fell 98.0% from the prior quarter. Over 3 fiscal years it compounded at -29.9% a year.

Context

  • Investing cash flow amounted to 10.6% of revenue in FY2025, up 10.4 pp from a year earlier.
  • Investing cash flow increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -95.0% toward the trailing-twelve-month pace of +218.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$61.17K-98.0% QoQ
Last fiscal yearDec 2025
-$4.71M-8236.8% YoY
LTMMar 2026
-$3.54M+218.3% YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-95.0%——
1 year-8236.8%——
3-year CAGR-29.9%——
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

USD · from the cash flow

Latest · FY2025
(4.71M) USD
Year-over-year change
-8236.8%

Investing Cash Flow vs competitors

How CPIX compares with its peers on the latest reported figures

  • CPIX's LTM Mar 2026 investing cash flow of $3.54M is the 2nd largest of the 4 companies compared; the peer median is $866.18K.
  • Its year-over-year change of +218.3% is the highest of 4, against a peer median of +68.4%.
  • Investing cash flow amounts to 8.4% of revenue for CPIX, versus a peer median of 14.6%.
CPIX Competitors Peer median
Investing Cash Flow for CPIX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LTRNLantern Pharma Inc.LTM Mar 2026$12.07M +68.4%+295.1%—
CPIXCumberland Pharmaceuticals Inc.LTM Mar 2026$3.54M +218.3%-29.9%8.4%
DYAIDyadic International, Inc.LTM Mar 2026$866.18K +217.2%—29.1%
CELUCelularity Inc.LTM Dec 2025$0 -100.0%—0.0%
Peer median (excluding CPIX) $866.18K+68.4%+295.1%14.6%

Competitors are the stored peer set for CPIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(3.6M)(5.65M)(6.28M)(6.48M)(2.86M)
Depreciation & Amortization4.61M5.33M5.77M6.04M5.29M
Deferred Income Tax(192.82K)0000
Stock-Based Compensation741.87K447.5K365.04K301.9K408.32K
Change in Working Capital8.18M10.97M4.63M1.29M2.16M
Accounts Receivables5.5M(6.12M)3.4M(1.94M)(5.24M)
Inventory4.82M1.38M(23.14K)2.41M2.24M
Accounts Payables(757.59K)15.07M3.72M(991.36K)6.71M
Other Working Capital(1.38M)644.92K(2.47M)1.82M(1.55M)
Other Non-Cash Items(3.39M)(2.64M)1.6M(1.77M)(59.95K)
Operating Cash Flow6.34M8.45M6.09M(612.19K)4.93M
Capital Expenditures(354.46K)(2.07M)(453.05K)(179.71K)(97.9K)
Acquisitions (Net)0(13.5M)000
Purchases of Investments(200K)000(4.48M)
Sales of Investments00000
Other Investing Activities52.57K1.9M347.36K237.56K(47K)
Investing Cash Flow(501.89K)(13.67M)(105.7K)57.84K(4.71M)
Debt Repayment01.2M(3.42M)2.49M(10.04M)
Common Stock Issued00005.27M
Common Stock Repurchased(1.39M)(1.05M)(740.53K)(579.05K)(263.48K)
Dividends Paid00000
Other Financing Activities(2.17M)(2.21M)(3.27M)(1.72M)(1.71M)
Financing Cash Flow(3.55M)(2.06M)(7.42M)196.9K(6.75M)
Effect of Forex Changes00000
Net Change in Cash2.29M(7.28M)(1.44M)(357.44K)(6.52M)
Free Cash Flow5.99M6.38M5.64M(791.9K)4.83M

Cumberland Pharmaceuticals Inc.

NASDAQ:CPIX

Intrinsic Alpha fair value

Locked

Current Price

$6.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.